Nuevolution A/S
Latest round
- Series B
Last raised
- Oct 2003
Total raised
- $20M
Investors
- 5
About Nuevolution A/S
Founded in 2001 and based in Copenhagen, Denmark, Nuevolution A/S operates as a biopharmaceutical company which develops Chemetics®, a technology for small molecule lead discovery applications. The company focuses on developing treatment within oncology and chronic inflammatory diseases.
Who invested in Nuevolution A/S
5 investors across 2 rounds
See all investors in Nuevolution A/S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nuevolution A/S
Who invested in Nuevolution A/S?
Nuevolution A/S has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuevolution A/S raised?
Nuevolution A/S has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nuevolution A/S last raise money?
Nuevolution A/S's most recent round on record is a Series B, in Oct 2003.
What does Nuevolution A/S do?
Founded in 2001 and based in Copenhagen, Denmark, Nuevolution A/S operates as a biopharmaceutical company which develops Chemetics®, a technology for small molecule lead discovery applications.
Where is Nuevolution A/S headquartered?
Nuevolution A/S is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Nuevolution A/S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Nuevolution A/S's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Nuevolution A/S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.